Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Repaka Krishna, Mohan"'
Autor:
Arjun, Chanda, Mukherjee, Archana, Bhatt, Jyotsna, Chaudhari, Pradip, Repaka, Krishna Mohan, Venkatesh, Meera, Samuel, Grace
Publikováno v:
In Applied Radiation and Isotopes January 2016 107:8-12
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Repaka Krishna Mohan, Ravi Seshan, Sandip Basu, S. S. Sachdev, Anupam Mathur, Vrinda Prashant, K.V. Vimalnath, Barkha Karkhanis, Navin Sakhare, Aruna Korde, Sharmila Banerjee, Chanda Arjun, Sudipta Chakraborty, Ashutosh Dash
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 32:266-273
Introduction: 177Lu-DOTA-TATE is a clinically useful and promising therapeutic radiopharmaceutical for peptide receptor radionuclide therapy of neuroendocrine tumors (NETs) overexpressing ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6f91d1b4814d07753f3cbcb23b236f1
https://doi.org/10.1089/cbr.2017.2208
https://doi.org/10.1089/cbr.2017.2208
Autor:
Kumar, Chandan, Sharma, Rohit, Repaka, Krishna Mohan, Pareri, Aanchal Udaynath, Dash, Ashutosh
Publikováno v:
Journal of Cancer Research & Therapeutics; Jul2021, Vol. 17 Issue 3, p943-950, 8p
Autor:
Anupam, Mathur, Vrinda, Prashant, Navin, Sakhare, Sudipta, Chakraborty, K V, Vimalnath, Repaka Krishna, Mohan, Chanda, Arjun, Barkha, Karkhanis, Ravi, Seshan, Sandip, Basu, Aruna, Korde, Sharmila, Banerjee, Ashutosh, Dash, Satbir Singh, Sachdev
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 32(7)
In an optimized protocol,A peptide/metal ratio of 1.5-3.0 is essential for complexation wherein radiolabeling yields90% are obtained minimizing freeA ready-to-use formulation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc39f8fda8c60310cbce3c5a81be49b1
https://pubmed.ncbi.nlm.nih.gov/28910148
https://pubmed.ncbi.nlm.nih.gov/28910148